Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Contrast Agents/Media Global Market - Forecast To 2027" report has been added to ResearchAndMarkets.com's offering.
Global contrast agents market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $7,033.5 million by 2027 due to the increasing incidence & prevalence of chronic diseases and demand for diagnostic & interventional radiology procedures, increase in aging population, Expansion of contrast agent indications, the growth of medical imaging in the emerging market, increasing research activities and favorable reimbursement.
North America accounted for the largest and fastest-growing region with revenue in 2020 by growing at high single digit CAGR from 2020 to 2027.
The factors such as increasing incidence and prevalence of the chronic disease, increase in aging population, approval of contrast agents for various indications, expanding indications of contrast agents, increasing number of contrast mediated diagnostic and interventional procedures, approach for the development of novel contrast agents by the startup companies and favorable reimbursement will drive North America contrast agent market.
The contrast agents global market is consolidated. The top five players occupy major share of the market share and the remaining is occupied by other players. All the existing players in this market are involved in developing new and advanced products to maintain their market shares and also acquiring companies for product expansion.
Some of the key players of the contrast agents market are
- Bayer Group
- Beijing Beilu Pharmaceutical Co. Ltd
- Bracco Group
- Dongkook Life Science
- Fujipharma Co Ltd
- GE Company (GE Healthcare)
- Guerbet
- Lantheus Medical Imaging Inc.
- Sanochemia Pharmaceutical AG
- Taejoon Pharm Co. Ltd
Market Analysis
Factors Influencing Market
Drivers and Opportunities
- Increasing Demand for Diagnostic and Interventional Radiology Procedures
- Increase in Aging Population
- Expansion in Indications of Contrast Media
- Increasing Research Activities Towards the Development of Novel Contrast Agents
- The Growth of Medical Imaging Technologies in Emerging Markets
- Favorable Reimbursement
Restraints and Threats
- Side Effect Associated With Contrast Agents
- Shortage of Radiologists
- Availability of Alternative Products
- Stringent Regulations for Contrast Agents
Regulatory Guidelines
- United States
- Europe
- China
- Japan
- South Korea
- India
Reimbursement Scenario
- Reimbursement Table
Technological Advancements
- Introduction
- Advancements in Computed Tomography Technology
- Nanoparticles Based Contrast Agents
- Multimodal Contrast Agents
- Manganese-Based Mri Contrast Agents
- Application of Ai in Contrast Imaging
- Bismuth Based Contrast Agents
- Supramolecular Macromolecular Organic Radical Contrast Agent
- Xenon Magnetic Resonance Imaging
- Upcoming Technologies/Products
Impact of Covid-19 on Imaging Procedures
Clinical Trials
Supply Chain Analysis
Porter's Five Force Analysis
Market Share Analysis by Major Players
- Global Contrast Agent Global Market
- Global X-Ray/CT Contrast Agents Market
- Global Mri Contrast Agents Market
- Global Ultrasound Based Contrast Agents Market
Computed Tomography Market - Number of Scans, Volume of Contrast Agent Consumed, and Market Size
Magnetic Resonance Imaging Market-Procedure Volume, Volume of Contrast Agent Consumed & Market Size
For more information about this report visit https://www.researchandmarkets.com/r/kn3ot6